XML 22 R12.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCK BASED AWARDS
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
STOCK BASED AWARDS

NOTE 6. STOCK BASED AWARDS

 

Stock-based compensation expense was reported as follows in the condensed consolidated statements of income within general and administrative expenses of $126 and $93 for the three months ended June 30, 2024 and 2023, respectively and $206 and $192 for the six months ended June 30, 2024 and 2023, respectively.

 

Stock Options

 

In May 2017, the shareholders approved the 2017 Stock Incentive Plan which authorized the issuance of 350,000 shares. An additional 50,000, 175,000 100,000 and 100,000 shares were authorized in March 2020, May 2022, May 2023 and May 2024, respectively.

 

We granted 22,000 service-based stock options during the three and six months ended June 30, 2024. The weighted-average grant-date fair value of options granted during the six months ended June 30, 2024 was $8.22. We granted 29,000 service-based stock options during the three and six months ended June 30, 2023. Weighted average stock option fair value assumptions and the weighted average grant date fair value of stock options granted were as follows:

 

   2024   2023 
Stock option fair value assumptions:          
Risk-free interest rate   4.40%   3.45%
Expected life (years)   6.0    6.5 
Dividend yield   0%   0%
Expected volatility   58%   60%
Weighted average grant date fair value of stock options granted  $6.47   $5.67 

 

 

Total compensation expense related to stock options was $65 and $121 for the three and six months ended June 30, 2024, respectively. Total compensation expense related to stock options was $55 and $123 for the three and six months ended June 30, 2023, respectively. As of June 30, 2024, there was $844 of unrecognized compensation related to stock options which will be recognized over a weighted average period of 3.8 years.

 

Following is the status of option activity for the six months ended and as of June 30, 2024:

 

   Shares  

Weighted-

Average

Exercise Price

Per Share

  

Weighted-

Average

Remaining

Contractual

Term
(in years)

  

Aggregate

Intrinsic Value

 
Outstanding – December 31, 2023   458,700   $6.63    6.53   $1,432 
Granted   22,000    11.06           
Exercised   (5,500)   5.42           
Forfeited   (9,600)   10.26           
Outstanding – June 30, 2024   465,600   $6.78    6.20   $3,150 
Exercisable on June 30, 2024   279,300   $4.67    4.60   $2,479 

 

Restricted Stock Units

 

During the three and six month periods ended June 30, 2024 and 2023, we granted 15,141 and 18,000 restricted stock units (“RSUs”), respectively, at an average grant price per share of $11.06 and $9.37, respectively, under our 2017 Stock Incentive Plan to non-employee directors which vest over two years. Total compensation expense related to the RSUs was $61 and $85 for the three and six months ended June 30, 2024 and 2023, respectively. Total compensation expense related to the RSUs was $38 and $69 for the three and six months ended June 30, 2023, respectively. As of June 30, 2024, total unrecognized compensation expense related to the RSUs was $220, which will vest over a weighted average period of 0.9 years.

 

Following is the status of restricted stock activity for the six months ended and as of June 30, 2024:

 

SCHEDULE OF RESTRICTED STOCK ACTIVITY

   Shares  

Weighted-

Average

Remaining

Vesting

Term
(in years)

  

Aggregate

Intrinsic Value

 
Outstanding – December 31, 2023   27,000    1.0   $254 
Granted   15,141           
Vested   (16,500)          
Forfeited   (1,500)          
Outstanding – June 30, 2024   24,141    0.9   $330